Global Cyanocobalamin Injection Market Insights and Forecast to 2026

Global Cyanocobalamin Injection Market Insights and Forecast to 2026

Table of Contents
1 Study Coverage
1.1 Cyanocobalamin Injection Product Introduction
1.2 Market Segments
1.3 Key Cyanocobalamin Injection Manufacturers Covered: Ranking by Revenue
1.4 Market by Type
1.4.1 Global Cyanocobalamin Injection Market Size Growth Rate by Type
1.4.2 Vitamins
1.4.3 Supplements
1.5 Market by Application
1.5.1 Global Cyanocobalamin Injection Market Size Growth Rate by Application
1.5.2 Hospitals
1.5.3 Clinics
1.5.4 Others
1.6 Study Objectives
1.7 Years Considered
2 Executive Summary
2.1 Global Cyanocobalamin Injection Market Size, Estimates and Forecasts
2.1.1 Global Cyanocobalamin Injection Revenue 2015-2026
2.1.2 Global Cyanocobalamin Injection Sales 2015-2026
2.2 Global Cyanocobalamin Injection, Market Size by Producing Regions: 2015 VS 2020 VS 2026
2.2.1 Global Cyanocobalamin Injection Retrospective Market Scenario in Sales by Region: 2015-2020
2.2.2 Global Cyanocobalamin Injection Retrospective Market Scenario in Revenue by Region: 2015-2020
3 Global Cyanocobalamin Injection Competitor Landscape by Players
3.1 Cyanocobalamin Injection Sales by Manufacturers
3.1.1 Cyanocobalamin Injection Sales by Manufacturers (2015-2020)
3.1.2 Cyanocobalamin Injection Sales Market Share by Manufacturers (2015-2020)
3.2 Cyanocobalamin Injection Revenue by Manufacturers
3.2.1 Cyanocobalamin Injection Revenue by Manufacturers (2015-2020)
3.2.2 Cyanocobalamin Injection Revenue Share by Manufacturers (2015-2020)
3.2.3 Global Cyanocobalamin Injection Market Concentration Ratio (CR5 and HHI) (2015-2020)
3.2.4 Global Top 10 and Top 5 Companies by Cyanocobalamin Injection Revenue in 2019
3.2.5 Global Cyanocobalamin Injection Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Cyanocobalamin Injection Price by Manufacturers
3.4 Cyanocobalamin Injection Manufacturing Base Distribution, Product Types
3.4.1 Cyanocobalamin Injection Manufacturers Manufacturing Base Distribution, Headquarters
3.4.2 Manufacturers Cyanocobalamin Injection Product Type
3.4.3 Date of International Manufacturers Enter into Cyanocobalamin Injection Market
3.5 Manufacturers Mergers & Acquisitions, Expansion Plans
4 Market Size by Type (2015-2026)
4.1 Global Cyanocobalamin Injection Market Size by Type (2015-2020)
4.1.1 Global Cyanocobalamin Injection Sales by Type (2015-2020)
4.1.2 Global Cyanocobalamin Injection Revenue by Type (2015-2020)
4.1.3 Cyanocobalamin Injection Average Selling Price (ASP) by Type (2015-2026)
4.2 Global Cyanocobalamin Injection Market Size Forecast by Type (2021-2026)
4.2.1 Global Cyanocobalamin Injection Sales Forecast by Type (2021-2026)
4.2.2 Global Cyanocobalamin Injection Revenue Forecast by Type (2021-2026)
4.2.3 Cyanocobalamin Injection Average Selling Price (ASP) Forecast by Type (2021-2026)
4.3 Global Cyanocobalamin Injection Market Share by Price Tier (2015-2020): Low-End, Mid-Range and High-End
5 Market Size by Application (2015-2026)
5.1 Global Cyanocobalamin Injection Market Size by Application (2015-2020)
5.1.1 Global Cyanocobalamin Injection Sales by Application (2015-2020)
5.1.2 Global Cyanocobalamin Injection Revenue by Application (2015-2020)
5.1.3 Cyanocobalamin Injection Price by Application (2015-2020)
5.2 Cyanocobalamin Injection Market Size Forecast by Application (2021-2026)
5.2.1 Global Cyanocobalamin Injection Sales Forecast by Application (2021-2026)
5.2.2 Global Cyanocobalamin Injection Revenue Forecast by Application (2021-2026)
5.2.3 Global Cyanocobalamin Injection Price Forecast by Application (2021-2026)
6 North America
6.1 North America Cyanocobalamin Injection by Country
6.1.1 North America Cyanocobalamin Injection Sales by Country
6.1.2 North America Cyanocobalamin Injection Revenue by Country
6.1.3 U.S.
6.1.4 Canada
6.2 North America Cyanocobalamin Injection Market Facts & Figures by Type
6.3 North America Cyanocobalamin Injection Market Facts & Figures by Application
7 Europe
7.1 Europe Cyanocobalamin Injection by Country
7.1.1 Europe Cyanocobalamin Injection Sales by Country
7.1.2 Europe Cyanocobalamin Injection Revenue by Country
7.1.3 Germany
7.1.4 France
7.1.5 U.K.
7.1.6 Italy
7.1.7 Russia
7.2 Europe Cyanocobalamin Injection Market Facts & Figures by Type
7.3 Europe Cyanocobalamin Injection Market Facts & Figures by Application
8 Asia Pacific
8.1 Asia Pacific Cyanocobalamin Injection by Region
8.1.1 Asia Pacific Cyanocobalamin Injection Sales by Region
8.1.2 Asia Pacific Cyanocobalamin Injection Revenue by Region
8.1.3 China
8.1.4 Japan
8.1.5 South Korea
8.1.6 India
8.1.7 Australia
8.1.8 Taiwan
8.1.9 Indonesia
8.1.10 Thailand
8.1.11 Malaysia
8.1.12 Philippines
8.1.13 Vietnam
8.2 Asia Pacific Cyanocobalamin Injection Market Facts & Figures by Type
8.3 Asia Pacific Cyanocobalamin Injection Market Facts & Figures by Application
9 Latin America
9.1 Latin America Cyanocobalamin Injection by Country
9.1.1 Latin America Cyanocobalamin Injection Sales by Country
9.1.2 Latin America Cyanocobalamin Injection Revenue by Country
9.1.3 Mexico
9.1.4 Brazil
9.1.5 Argentina
9.2 Central & South America Cyanocobalamin Injection Market Facts & Figures by Type
9.3 Central & South America Cyanocobalamin Injection Market Facts & Figures by Application
10 Middle East and Africa
10.1 Middle East and Africa Cyanocobalamin Injection by Country
10.1.1 Middle East and Africa Cyanocobalamin Injection Sales by Country
10.1.2 Middle East and Africa Cyanocobalamin Injection Revenue by Country
10.1.3 Turkey
10.1.4 Saudi Arabia
10.1.5 U.A.E
10.2 Middle East and Africa Cyanocobalamin Injection Market Facts & Figures by Type
10.3 Middle East and Africa Cyanocobalamin Injection Market Facts & Figures by Application
11 Company Profiles
11.1 Luitpold Pharmaceuticals
11.1.1 Luitpold Pharmaceuticals Corporation Information
11.1.2 Luitpold Pharmaceuticals Description and Business Overview
11.1.3 Luitpold Pharmaceuticals Sales, Revenue and Gross Margin (2015-2020)
11.1.4 Luitpold Pharmaceuticals Cyanocobalamin Injection Products Offered
11.1.5 Luitpold Pharmaceuticals Related Developments
11.2 Luitpold Pharmaceuticals (Daiichi Sankyo)
11.2.1 Luitpold Pharmaceuticals (Daiichi Sankyo) Corporation Information
11.2.2 Luitpold Pharmaceuticals (Daiichi Sankyo) Description and Business Overview
11.2.3 Luitpold Pharmaceuticals (Daiichi Sankyo) Sales, Revenue and Gross Margin (2015-2020)
11.2.4 Luitpold Pharmaceuticals (Daiichi Sankyo) Cyanocobalamin Injection Products Offered
11.2.5 Luitpold Pharmaceuticals (Daiichi Sankyo) Related Developments
11.3 Endo International
11.3.1 Endo International Corporation Information
11.3.2 Endo International Description and Business Overview
11.3.3 Endo International Sales, Revenue and Gross Margin (2015-2020)
11.3.4 Endo International Cyanocobalamin Injection Products Offered
11.3.5 Endo International Related Developments
11.4 Bristol-Myers Squibb
11.4.1 Bristol-Myers Squibb Corporation Information
11.4.2 Bristol-Myers Squibb Description and Business Overview
11.4.3 Bristol-Myers Squibb Sales, Revenue and Gross Margin (2015-2020)
11.4.4 Bristol-Myers Squibb Cyanocobalamin Injection Products Offered
11.4.5 Bristol-Myers Squibb Related Developments
11.5 Sanofi-Aventis
11.5.1 Sanofi-Aventis Corporation Information
11.5.2 Sanofi-Aventis Description and Business Overview
11.5.3 Sanofi-Aventis Sales, Revenue and Gross Margin (2015-2020)
11.5.4 Sanofi-Aventis Cyanocobalamin Injection Products Offered
11.5.5 Sanofi-Aventis Related Developments
11.6 Jamieson
11.6.1 Jamieson Corporation Information
11.6.2 Jamieson Description and Business Overview
11.6.3 Jamieson Sales, Revenue and Gross Margin (2015-2020)
11.6.4 Jamieson Cyanocobalamin Injection Products Offered
11.6.5 Jamieson Related Developments
11.7 Teva (Actavis)
11.7.1 Teva (Actavis) Corporation Information
11.7.2 Teva (Actavis) Description and Business Overview
11.7.3 Teva (Actavis) Sales, Revenue and Gross Margin (2015-2020)
11.7.4 Teva (Actavis) Cyanocobalamin Injection Products Offered
11.7.5 Teva (Actavis) Related Developments
11.8 Merck
11.8.1 Merck Corporation Information
11.8.2 Merck Description and Business Overview
11.8.3 Merck Sales, Revenue and Gross Margin (2015-2020)
11.8.4 Merck Cyanocobalamin Injection Products Offered
11.8.5 Merck Related Developments
11.9 Mylan
11.9.1 Mylan Corporation Information
11.9.2 Mylan Description and Business Overview
11.9.3 Mylan Sales, Revenue and Gross Margin (2015-2020)
11.9.4 Mylan Cyanocobalamin Injection Products Offered
11.9.5 Mylan Related Developments
11.10 Bayer HealthCare
11.10.1 Bayer HealthCare Corporation Information
11.10.2 Bayer HealthCare Description and Business Overview
11.10.3 Bayer HealthCare Sales, Revenue and Gross Margin (2015-2020)
11.10.4 Bayer HealthCare Cyanocobalamin Injection Products Offered
11.10.5 Bayer HealthCare Related Developments
11.1 Luitpold Pharmaceuticals
11.1.1 Luitpold Pharmaceuticals Corporation Information
11.1.2 Luitpold Pharmaceuticals Description and Business Overview
11.1.3 Luitpold Pharmaceuticals Sales, Revenue and Gross Margin (2015-2020)
11.1.4 Luitpold Pharmaceuticals Cyanocobalamin Injection Products Offered
11.1.5 Luitpold Pharmaceuticals Related Developments
11.12 ANGELINI
11.12.1 ANGELINI Corporation Information
11.12.2 ANGELINI Description and Business Overview
11.12.3 ANGELINI Sales, Revenue and Gross Margin (2015-2020)
11.12.4 ANGELINI Products Offered
11.12.5 ANGELINI Related Developments
11.13 Biological E
11.13.1 Biological E Corporation Information
11.13.2 Biological E Description and Business Overview
11.13.3 Biological E Sales, Revenue and Gross Margin (2015-2020)
11.13.4 Biological E Products Offered
11.13.5 Biological E Related Developments
11.14 CCEPCD
11.14.1 CCEPCD Corporation Information
11.14.2 CCEPCD Description and Business Overview
11.14.3 CCEPCD Sales, Revenue and Gross Margin (2015-2020)
11.14.4 CCEPCD Products Offered
11.14.5 CCEPCD Related Developments
11.15 Huaxin Pharmaceutical
11.15.1 Huaxin Pharmaceutical Corporation Information
11.15.2 Huaxin Pharmaceutical Description and Business Overview
11.15.3 Huaxin Pharmaceutical Sales, Revenue and Gross Margin (2015-2020)
11.15.4 Huaxin Pharmaceutical Products Offered
11.15.5 Huaxin Pharmaceutical Related Developments
12 Future Forecast by Regions (Countries) (2021-2026)
12.1 Cyanocobalamin Injection Market Estimates and Projections by Region
12.1.1 Global Cyanocobalamin Injection Sales Forecast by Regions 2021-2026
12.1.2 Global Cyanocobalamin Injection Revenue Forecast by Regions 2021-2026
12.2 North America Cyanocobalamin Injection Market Size Forecast (2021-2026)
12.2.1 North America: Cyanocobalamin Injection Sales Forecast (2021-2026)
12.2.2 North America: Cyanocobalamin Injection Revenue Forecast (2021-2026)
12.2.3 North America: Cyanocobalamin Injection Market Size Forecast by Country (2021-2026)
12.3 Europe Cyanocobalamin Injection Market Size Forecast (2021-2026)
12.3.1 Europe: Cyanocobalamin Injection Sales Forecast (2021-2026)
12.3.2 Europe: Cyanocobalamin Injection Revenue Forecast (2021-2026)
12.3.3 Europe: Cyanocobalamin Injection Market Size Forecast by Country (2021-2026)
12.4 Asia Pacific Cyanocobalamin Injection Market Size Forecast (2021-2026)
12.4.1 Asia Pacific: Cyanocobalamin Injection Sales Forecast (2021-2026)
12.4.2 Asia Pacific: Cyanocobalamin Injection Revenue Forecast (2021-2026)
12.4.3 Asia Pacific: Cyanocobalamin Injection Market Size Forecast by Region (2021-2026)
12.5 Latin America Cyanocobalamin Injection Market Size Forecast (2021-2026)
12.5.1 Latin America: Cyanocobalamin Injection Sales Forecast (2021-2026)
12.5.2 Latin America: Cyanocobalamin Injection Revenue Forecast (2021-2026)
12.5.3 Latin America: Cyanocobalamin Injection Market Size Forecast by Country (2021-2026)
12.6 Middle East and Africa Cyanocobalamin Injection Market Size Forecast (2021-2026)
12.6.1 Middle East and Africa: Cyanocobalamin Injection Sales Forecast (2021-2026)
12.6.2 Middle East and Africa: Cyanocobalamin Injection Revenue Forecast (2021-2026)
12.6.3 Middle East and Africa: Cyanocobalamin Injection Market Size Forecast by Country (2021-2026)
13 Market Opportunities, Challenges, Risks and Influences Factors Analysis
13.1 Market Opportunities and Drivers
13.2 Market Challenges
13.3 Market Risks/Restraints
13.4 Porter's Five Forces Analysis
13.5 Primary Interviews with Key Cyanocobalamin Injection Players (Opinion Leaders)
14 Value Chain and Sales Channels Analysis
14.1 Value Chain Analysis
14.2 Cyanocobalamin Injection Customers
14.3 Sales Channels Analysis
14.3.1 Sales Channels
14.3.2 Distributors
15 Research Findings and Conclusion
16 Appendix
16.1 Research Methodology
16.1.1 Methodology/Research Approach
16.1.2 Data Source
16.2 Author Details
16.3 Disclaimer
List of Tables
Table 1. Cyanocobalamin Injection Market Segments
Table 2. Ranking of Global Top Cyanocobalamin Injection Manufacturers by Revenue (US$ Million) in 2019
Table 3. Global Cyanocobalamin Injection Market Size Growth Rate by Type 2020-2026 (K Doses) & (US$ Million)
Table 4. Major Manufacturers of Vitamins
Table 5. Major Manufacturers of Supplements
Table 6. Global Cyanocobalamin Injection Market Size Growth Rate by Application 2020-2026 (K Doses)
Table 7. Global Cyanocobalamin Injection Market Size by Region (K Doses) & (US$ Million): 2020 VS 2026
Table 8. Global Cyanocobalamin Injection Sales by Regions 2015-2020 (K Doses)
Table 9. Global Cyanocobalamin Injection Sales Market Share by Regions (2015-2020)
Table 10. Global Cyanocobalamin Injection Revenue by Regions 2015-2020 (US$ Million)
Table 11. Global Cyanocobalamin Injection Sales by Manufacturers (2015-2020) (K Doses)
Table 12. Global Cyanocobalamin Injection Sales Share by Manufacturers (2015-2020)
Table 13. Global Cyanocobalamin Injection Manufacturers Market Concentration Ratio (CR5 and HHI) (2015-2020)
Table 14. Global Cyanocobalamin Injection by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Cyanocobalamin Injection as of 2019)
Table 15. Cyanocobalamin Injection Revenue by Manufacturers (2015-2020) (US$ Million)
Table 16. Cyanocobalamin Injection Revenue Share by Manufacturers (2015-2020)
Table 17. Key Manufacturers Cyanocobalamin Injection Price (2015-2020) (USD/Dose)
Table 18. Cyanocobalamin Injection Manufacturers Manufacturing Base Distribution and Headquarters
Table 19. Manufacturers Cyanocobalamin Injection Product Type
Table 20. Date of International Manufacturers Enter into Cyanocobalamin Injection Market
Table 21. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 22. Global Cyanocobalamin Injection Sales by Type (2015-2020) (K Doses)
Table 23. Global Cyanocobalamin Injection Sales Share by Type (2015-2020)
Table 24. Global Cyanocobalamin Injection Revenue by Type (2015-2020) (US$ Million)
Table 25. Global Cyanocobalamin Injection Revenue Share by Type (2015-2020)
Table 26. Cyanocobalamin Injection Average Selling Price (ASP) by Type 2015-2020 (USD/Dose)
Table 27. Global Cyanocobalamin Injection Sales by Application (2015-2020) (K Doses)
Table 28. Global Cyanocobalamin Injection Sales Share by Application (2015-2020)
Table 29. North America Cyanocobalamin Injection Sales by Country (2015-2020) (K Doses)
Table 30. North America Cyanocobalamin Injection Sales Market Share by Country (2015-2020)
Table 31. North America Cyanocobalamin Injection Revenue by Country (2015-2020) (US$ Million)
Table 32. North America Cyanocobalamin Injection Revenue Market Share by Country (2015-2020)
Table 33. North America Cyanocobalamin Injection Sales by Type (2015-2020) (K Doses)
Table 34. North America Cyanocobalamin Injection Sales Market Share by Type (2015-2020)
Table 35. North America Cyanocobalamin Injection Sales by Application (2015-2020) (K Doses)
Table 36. North America Cyanocobalamin Injection Sales Market Share by Application (2015-2020)
Table 37. Europe Cyanocobalamin Injection Sales by Country (2015-2020) (K Doses)
Table 38. Europe Cyanocobalamin Injection Sales Market Share by Country (2015-2020)
Table 39. Europe Cyanocobalamin Injection Revenue by Country (2015-2020) (US$ Million)
Table 40. Europe Cyanocobalamin Injection Revenue Market Share by Country (2015-2020)
Table 41. Europe Cyanocobalamin Injection Sales by Type (2015-2020) (K Doses)
Table 42. Europe Cyanocobalamin Injection Sales Market Share by Type (2015-2020)
Table 43. Europe Cyanocobalamin Injection Sales by Application (2015-2020) (K Doses)
Table 44. Europe Cyanocobalamin Injection Sales Market Share by Application (2015-2020)
Table 45. Asia Pacific Cyanocobalamin Injection Sales by Region (2015-2020) (K Doses)
Table 46. Asia Pacific Cyanocobalamin Injection Sales Market Share by Region (2015-2020)
Table 47. Asia Pacific Cyanocobalamin Injection Revenue by Region (2015-2020) (US$ Million)
Table 48. Asia Pacific Cyanocobalamin Injection Revenue Market Share by Region (2015-2020)
Table 49. Asia Pacific Cyanocobalamin Injection Sales by Type (2015-2020) (K Doses)
Table 50. Asia Pacific Cyanocobalamin Injection Sales Market Share by Type (2015-2020)
Table 51. Asia Pacific Cyanocobalamin Injection Sales by Application (2015-2020) (K Doses)
Table 52. Asia Pacific Cyanocobalamin Injection Sales Market Share by Application (2015-2020)
Table 53. Latin America Cyanocobalamin Injection Sales by Country (2015-2020) (K Doses)
Table 54. Latin America Cyanocobalamin Injection Sales Market Share by Country (2015-2020)
Table 55. Latin Americaa Cyanocobalamin Injection Revenue by Country (2015-2020) (US$ Million)
Table 56. Latin America Cyanocobalamin Injection Revenue Market Share by Country (2015-2020)
Table 57. Latin America Cyanocobalamin Injection Sales by Type (2015-2020) (K Doses)
Table 58. Latin America Cyanocobalamin Injection Sales Market Share by Type (2015-2020)
Table 59. Latin America Cyanocobalamin Injection Sales by Application (2015-2020) (K Doses)
Table 60. Latin America Cyanocobalamin Injection Sales Market Share by Application (2015-2020)
Table 61. Middle East and Africa Cyanocobalamin Injection Sales by Country (2015-2020) (K Doses)
Table 62. Middle East and Africa Cyanocobalamin Injection Sales Market Share by Country (2015-2020)
Table 63. Middle East and Africa Cyanocobalamin Injection Revenue by Country (2015-2020) (US$ Million)
Table 64. Middle East and Africa Cyanocobalamin Injection Revenue Market Share by Country (2015-2020)
Table 65. Middle East and Africa Cyanocobalamin Injection Sales by Type (2015-2020) (K Doses)
Table 66. Middle East and Africa Cyanocobalamin Injection Sales Market Share by Type (2015-2020)
Table 67. Middle East and Africa Cyanocobalamin Injection Sales by Application (2015-2020) (K Doses)
Table 68. Middle East and Africa Cyanocobalamin Injection Sales Market Share by Application (2015-2020)
Table 69. Luitpold Pharmaceuticals Corporation Information
Table 70. Luitpold Pharmaceuticals Description and Major Businesses
Table 71. Luitpold Pharmaceuticals Cyanocobalamin Injection Production (K Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2015-2020)
Table 72. Luitpold Pharmaceuticals Product
Table 73. Luitpold Pharmaceuticals Recent Development
Table 74. Luitpold Pharmaceuticals (Daiichi Sankyo) Corporation Information
Table 75. Luitpold Pharmaceuticals (Daiichi Sankyo) Description and Major Businesses
Table 76. Luitpold Pharmaceuticals (Daiichi Sankyo) Cyanocobalamin Injection Production (K Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2015-2020)
Table 77. Luitpold Pharmaceuticals (Daiichi Sankyo) Product
Table 78. Luitpold Pharmaceuticals (Daiichi Sankyo) Recent Development
Table 79. Endo International Corporation Information
Table 80. Endo International Description and Major Businesses
Table 81. Endo International Cyanocobalamin Injection Production (K Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2015-2020)
Table 82. Endo International Product
Table 83. Endo International Recent Development
Table 84. Bristol-Myers Squibb Corporation Information
Table 85. Bristol-Myers Squibb Description and Major Businesses
Table 86. Bristol-Myers Squibb Cyanocobalamin Injection Production (K Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2015-2020)
Table 87. Bristol-Myers Squibb Product
Table 88. Bristol-Myers Squibb Recent Development
Table 89. Sanofi-Aventis Corporation Information
Table 90. Sanofi-Aventis Description and Major Businesses
Table 91. Sanofi-Aventis Cyanocobalamin Injection Production (K Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2015-2020)
Table 92. Sanofi-Aventis Product
Table 93. Sanofi-Aventis Recent Development
Table 94. Jamieson Corporation Information
Table 95. Jamieson Description and Major Businesses
Table 96. Jamieson Cyanocobalamin Injection Production (K Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2015-2020)
Table 97. Jamieson Product
Table 98. Jamieson Recent Development
Table 99. Teva (Actavis) Corporation Information
Table 100. Teva (Actavis) Description and Major Businesses
Table 101. Teva (Actavis) Cyanocobalamin Injection Production (K Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2015-2020)
Table 102. Teva (Actavis) Product
Table 103. Teva (Actavis) Recent Development
Table 104. Merck Corporation Information
Table 105. Merck Description and Major Businesses
Table 106. Merck Cyanocobalamin Injection Production (K Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2015-2020)
Table 107. Merck Product
Table 108. Merck Recent Development
Table 109. Mylan Corporation Information
Table 110. Mylan Description and Major Businesses
Table 111. Mylan Cyanocobalamin Injection Production (K Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2015-2020)
Table 112. Mylan Product
Table 113. Mylan Recent Development
Table 114. Bayer HealthCare Corporation Information
Table 115. Bayer HealthCare Description and Major Businesses
Table 116. Bayer HealthCare Cyanocobalamin Injection Production (K Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2015-2020)
Table 117. Bayer HealthCare Product
Table 118. Bayer HealthCare Recent Development
Table 119. Pfizer Corporation Information
Table 120. Pfizer Description and Major Businesses
Table 121. Pfizer Cyanocobalamin Injection Sales (K Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2015-2020)
Table 122. Pfizer Product
Table 123. Pfizer Recent Development
Table 124. ANGELINI Corporation Information
Table 125. ANGELINI Description and Major Businesses
Table 126. ANGELINI Cyanocobalamin Injection Sales (K Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2015-2020)
Table 127. ANGELINI Product
Table 128. ANGELINI Recent Development
Table 129. Biological E Corporation Information
Table 130. Biological E Description and Major Businesses
Table 131. Biological E Cyanocobalamin Injection Sales (K Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2015-2020)
Table 132. Biological E Product
Table 133. Biological E Recent Development
Table 134. CCEPCD Corporation Information
Table 135. CCEPCD Description and Major Businesses
Table 136. CCEPCD Cyanocobalamin Injection Sales (K Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2015-2020)
Table 137. CCEPCD Product
Table 138. CCEPCD Recent Development
Table 139. Huaxin Pharmaceutical Corporation Information
Table 140. Huaxin Pharmaceutical Description and Major Businesses
Table 141. Huaxin Pharmaceutical Cyanocobalamin Injection Sales (K Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2015-2020)
Table 142. Huaxin Pharmaceutical Product
Table 143. Huaxin Pharmaceutical Recent Development
Table 144. Global Cyanocobalamin Injection Sales Forecast by Regions (2021-2026) (K Doses)
Table 145. Global Cyanocobalamin Injection Sales Market Share Forecast by Regions (2021-2026)
Table 146. Global Cyanocobalamin Injection Revenue Forecast by Regions (2021-2026) (US$ Million)
Table 147. Global Cyanocobalamin Injection Revenue Market Share Forecast by Regions (2021-2026)
Table 148. North America: Cyanocobalamin Injection Sales Forecast by Country (2021-2026) (K Doses)
Table 149. North America: Cyanocobalamin Injection Revenue Forecast by Country (2021-2026) (US$ Million)
Table 150. Europe: Cyanocobalamin Injection Sales Forecast by Country (2021-2026) (K Doses)
Table 151. Europe: Cyanocobalamin Injection Revenue Forecast by Country (2021-2026) (US$ Million)
Table 152. Asia Pacific: Cyanocobalamin Injection Sales Forecast by Region (2021-2026) (K Doses)
Table 153. Asia Pacific: Cyanocobalamin Injection Revenue Forecast by Region (2021-2026) (US$ Million)
Table 154. Latin America: Cyanocobalamin Injection Sales Forecast by Country (2021-2026) (K Doses)
Table 155. Latin America: Cyanocobalamin Injection Revenue Forecast by Country (2021-2026) (US$ Million)
Table 156. Middle East and Africa: Cyanocobalamin Injection Sales Forecast by Country (2021-2026) (K Doses)
Table 157. Middle East and Africa: Cyanocobalamin Injection Revenue Forecast by Country (2021-2026) (US$ Million)
Table 158. Key Opportunities and Drivers: Impact Analysis (2021-2026)
Table 159. Key Challenges
Table 160. Market Risks
Table 161. Main Points Interviewed from Key Cyanocobalamin Injection Players
Table 162. Cyanocobalamin Injection Customers List
Table 163. Cyanocobalamin Injection Distributors List
Table 164. Research Programs/Design for This Report
Table 165. Key Data Information from Secondary Sources
Table 166. Key Data Information from Primary Sources
List of Figures
Figure 1. Cyanocobalamin Injection Product Picture
Figure 2. Global Cyanocobalamin Injection Sales Market Share by Type in 2020 & 2026
Figure 3. Vitamins Product Picture
Figure 4. Supplements Product Picture
Figure 5. Global Cyanocobalamin Injection Sales Market Share by Application in 2020 & 2026
Figure 6. Hospitals
Figure 7. Clinics
Figure 8. Others
Figure 9. Cyanocobalamin Injection Report Years Considered
Figure 10. Global Cyanocobalamin Injection Market Size 2015-2026 (US$ Million)
Figure 11. Global Cyanocobalamin Injection Sales 2015-2026 (K Doses)
Figure 12. Global Cyanocobalamin Injection Market Size Market Share by Region: 2020 Versus 2026
Figure 13. Global Cyanocobalamin Injection Sales Market Share by Region (2015-2020)
Figure 14. Global Cyanocobalamin Injection Sales Market Share by Region in 2019
Figure 15. Global Cyanocobalamin Injection Revenue Market Share by Region (2015-2020)
Figure 16. Global Cyanocobalamin Injection Revenue Market Share by Region in 2019
Figure 17. Global Cyanocobalamin Injection Sales Share by Manufacturer in 2019
Figure 18. The Top 10 and 5 Players Market Share by Cyanocobalamin Injection Revenue in 2019
Figure 19. Cyanocobalamin Injection Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2015 VS 2019
Figure 20. Global Cyanocobalamin Injection Sales Market Share by Type (2015-2020)
Figure 21. Global Cyanocobalamin Injection Sales Market Share by Type in 2019
Figure 22. Global Cyanocobalamin Injection Revenue Market Share by Type (2015-2020)
Figure 23. Global Cyanocobalamin Injection Revenue Market Share by Type in 2019
Figure 24. Global Cyanocobalamin Injection Market Share by Price Range (2015-2020)
Figure 25. Global Cyanocobalamin Injection Sales Market Share by Application (2015-2020)
Figure 26. Global Cyanocobalamin Injection Sales Market Share by Application in 2019
Figure 27. Global Cyanocobalamin Injection Revenue Market Share by Application (2015-2020)
Figure 28. Global Cyanocobalamin Injection Revenue Market Share by Application in 2019
Figure 29. North America Cyanocobalamin Injection Sales Growth Rate 2015-2020 (K Doses)
Figure 30. North America Cyanocobalamin Injection Revenue Growth Rate 2015-2020 (US$ Million)
Figure 31. North America Cyanocobalamin Injection Sales Market Share by Country in 2019
Figure 32. North America Cyanocobalamin Injection Revenue Market Share by Country in 2019
Figure 33. U.S. Cyanocobalamin Injection Sales Growth Rate (2015-2020) (K Doses)
Figure 34. U.S. Cyanocobalamin Injection Revenue Growth Rate (2015-2020) (US$ Million)
Figure 35. Canada Cyanocobalamin Injection Sales Growth Rate (2015-2020) (K Doses)
Figure 36. Canada Cyanocobalamin Injection Revenue Growth Rate (2015-2020) (US$ Million)
Figure 37. North America Cyanocobalamin Injection Market Share by Type in 2019
Figure 38. North America Cyanocobalamin Injection Market Share by Application in 2019
Figure 39. Europe Cyanocobalamin Injection Sales Growth Rate 2015-2020 (K Doses)
Figure 40. Europe Cyanocobalamin Injection Revenue Growth Rate 2015-2020 (US$ Million)
Figure 41. Europe Cyanocobalamin Injection Sales Market Share by Country in 2019
Figure 42. Europe Cyanocobalamin Injection Revenue Market Share by Country in 2019
Figure 43. Germany Cyanocobalamin Injection Sales Growth Rate (2015-2020) (K Doses)
Figure 44. Germany Cyanocobalamin Injection Revenue Growth Rate (2015-2020) (US$ Million)
Figure 45. France Cyanocobalamin Injection Sales Growth Rate (2015-2020) (K Doses)
Figure 46. France Cyanocobalamin Injection Revenue Growth Rate (2015-2020) (US$ Million)
Figure 47. U.K. Cyanocobalamin Injection Sales Growth Rate (2015-2020) (K Doses)
Figure 48. U.K. Cyanocobalamin Injection Revenue Growth Rate (2015-2020) (US$ Million)
Figure 49. Italy Cyanocobalamin Injection Sales Growth Rate (2015-2020) (K Doses)
Figure 50. Italy Cyanocobalamin Injection Revenue Growth Rate (2015-2020) (US$ Million)
Figure 51. Russia Cyanocobalamin Injection Sales Growth Rate (2015-2020) (K Doses)
Figure 52. Russia Cyanocobalamin Injection Revenue Growth Rate (2015-2020) (US$ Million)
Figure 53. Europe Cyanocobalamin Injection Market Share by Type in 2019
Figure 54. Europe Cyanocobalamin Injection Market Share by Application in 2019
Figure 55. Asia Pacific Cyanocobalamin Injection Sales Growth Rate 2015-2020 (K Doses)
Figure 56. Asia Pacific Cyanocobalamin Injection Revenue Growth Rate 2015-2020 (US$ Million)
Figure 57. Asia Pacific Cyanocobalamin Injection Sales Market Share by Region in 2019
Figure 58. Asia Pacific Cyanocobalamin Injection Revenue Market Share by Region in 2019
Figure 59. China Cyanocobalamin Injection Sales Growth Rate (2015-2020) (K Doses)
Figure 60. China Cyanocobalamin Injection Revenue Growth Rate (2015-2020) (US$ Million)
Figure 61. Japan Cyanocobalamin Injection Sales Growth Rate (2015-2020) (K Doses)
Figure 62. Japan Cyanocobalamin Injection Revenue Growth Rate (2015-2020) (US$ Million)
Figure 63. South Korea Cyanocobalamin Injection Sales Growth Rate (2015-2020) (K Doses)
Figure 64. South Korea Cyanocobalamin Injection Revenue Growth Rate (2015-2020) (US$ Million)
Figure 65. India Cyanocobalamin Injection Sales Growth Rate (2015-2020) (K Doses)
Figure 66. India Cyanocobalamin Injection Revenue Growth Rate (2015-2020) (US$ Million)
Figure 67. Australia Cyanocobalamin Injection Sales Growth Rate (2015-2020) (K Doses)
Figure 68. Australia Cyanocobalamin Injection Revenue Growth Rate (2015-2020) (US$ Million)
Figure 69. Taiwan Cyanocobalamin Injection Sales Growth Rate (2015-2020) (K Doses)
Figure 70. Taiwan Cyanocobalamin Injection Revenue Growth Rate (2015-2020) (US$ Million)
Figure 71. Indonesia Cyanocobalamin Injection Sales Growth Rate (2015-2020) (K Doses)
Figure 72. Indonesia Cyanocobalamin Injection Revenue Growth Rate (2015-2020) (US$ Million)
Figure 73. Thailand Cyanocobalamin Injection Sales Growth Rate (2015-2020) (K Doses)
Figure 74. Thailand Cyanocobalamin Injection Revenue Growth Rate (2015-2020) (US$ Million)
Figure 75. Malaysia Cyanocobalamin Injection Sales Growth Rate (2015-2020) (K Doses)
Figure 76. Malaysia Cyanocobalamin Injection Revenue Growth Rate (2015-2020) (US$ Million)
Figure 77. Philippines Cyanocobalamin Injection Sales Growth Rate (2015-2020) (K Doses)
Figure 78. Philippines Cyanocobalamin Injection Revenue Growth Rate (2015-2020) (US$ Million)
Figure 79. Vietnam Cyanocobalamin Injection Sales Growth Rate (2015-2020) (K Doses)
Figure 80. Vietnam Cyanocobalamin Injection Revenue Growth Rate (2015-2020) (US$ Million)
Figure 81. Asia Pacific Cyanocobalamin Injection Market Share by Type in 2019
Figure 82. Asia Pacific Cyanocobalamin Injection Market Share by Application in 2019
Figure 83. Latin America Cyanocobalamin Injection Sales Growth Rate 2015-2020 (K Doses)

• Clinical Results in Diabetics To Be Boosted By Smart Artificial Beta Cells

For a long time, the cure for diabetes type 1 and type 2 has relied on agonizing insulin shots for patients or insulin infusion via mechanical pumps. Regarding this, experts have been creating artificial pancreatic beta cells with the he…

• High-speed Data Transmission And High Volume Needs Propel Fiber Optic Connectors Market

Fiber optic connectors are a substantial fragment of the global telecommunication industry. Optical fibers are joined using fiber optic connectors, which allow the light conduction between two consecutive optical fibers. An additional im…

• Extensive Use of Digital Technologies for Diagnostic Applications To Boost Global Optical Imaging Market

The global optical imaging system market is predicted to reach US$ 3 billion by 2024. It is expected to grow at a stable rate and will post a CAGR of more than 8% in the coming years. The growing market infiltration of digital …

• Foremost Trends In Global Pet Care Market

The global pet care market is foretold to improve in the forthcoming years as matched to the preceding years and will showcase better sales in various market segments. It is estimated that the global pet care market will grow at a CAGR o…

• China To Review Its Food Security Laws

China has arisen as the globe’s firmest developing economy. In addition, China brags about the biggest population pool in the world. In recent times, the one child policy in the republic was terminated. This is anticipated to upsur…

Global Antioxidant Vitamins Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 100

The global Antioxidant Vitamins market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Antioxidant Vitamins is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Antioxidant Vitamins is estimated to increase from $ million in 2023 to reach $ millio......

Global Clavulanate Potassium Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 86

The global Clavulanate Potassium market was valued at US$ 446.6 million in 2023 and is anticipated to reach US$ 637.2 million by 2030, witnessing a CAGR of 5.2% during The forecast period 2024-2030. North American market for Clavulanate Potassium is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Clavulanate Potassium is estimated to increase from $ million in 2023......

Global Amoxicillin Sodium Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 84

The global Amoxicillin Sodium market was valued at US$ 460.9 million in 2023 and is anticipated to reach US$ 735.1 million by 2030, witnessing a CAGR of 7.0% during The forecast period 2024-2030. North American market for Amoxicillin Sodium is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Amoxicillin Sodium is estimated to increase from $ million in 2023 to reach......

Global Melatonin Supplements Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 106

The global Melatonin Supplements market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Melatonin Supplements is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Melatonin Supplements is estimated to increase from $ million in 2023 to reach $ mil......

Global Sleeping Pills (Prescription Drugs) Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 93

The global Sleeping Pills (Prescription Drugs) market was valued at US$ 1022.3 million in 2023 and is anticipated to reach US$ 1437.8 million by 2030, witnessing a CAGR of 4.9% during The forecast period 2024-2030. The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during The next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, The chemical......

Global Sleeping Pills Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 94

The global Sleeping Pills market was valued at US$ 2042.3 million in 2023 and is anticipated to reach US$ 2979.5 million by 2030, witnessing a CAGR of 3.8% during The forecast period 2024-2030. The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during The next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, The chemical drug market is estim......

Global Zinc Oral Drops Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 85

The global Zinc Oral Drops market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Zinc Oral Drops is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Zinc Oral Drops is estimated to increase from $ million in 2023 to reach $ million by 2030, at a......

Global Zinc Drops Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 85

The global Zinc Drops market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Zinc Drops is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Zinc Drops is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % duri......

Global Anti-Infectives Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 78

The global Anti-Infectives market was valued at US$ 22700 million in 2023 and is anticipated to reach US$ 27480 million by 2030, witnessing a CAGR of 2.3% during The forecast period 2024-2030. The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during The next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, The chemical drug market is estima......

We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s. Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors. Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business. Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision. Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us. Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done. Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - [email protected] / +1 888 391 5441 )

• Ad Hoc
• Pay - as - you - go / Bucket Subscriptions
• Fixed Cost for #of reports
• Customize / Personalize as per your needs